$40M tax break to drugmaker accused of pushing opioids

Eric Kiefer reports for the Bloomfield Patch
An international pharmaceutical company will receive a $40 million, performance-based tax break to move its U.S. headquarters from Pennsylvania to New Jersey, despite multiple lawsuits accusing it of contributing to the national opioid crisis.
Last week, Gov. Phil Murphy announced that Teva Pharmaceuticals USA, the North American arm of Teva Pharmaceuticals Industries Ltd., will relocate its U.S. headquarters from North Wales, Pennsylvania to Parsippany-Troy Hills, bringing “more than 1,000 high-wage jobs to New Jersey.”
The governor’s press statement about the relocation didn’t mention that Teva USA was named alongside several other drug manufacturers in a 2017 lawsuit launched by the City of Newark, which accused the company – and 10 of its peers – of “hiding behind the scene as the connection/supplier to local drug dealers.”
$40M tax break to drugmaker accused of pushing opioids Read More »






